{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:24:06Z","timestamp":1785507846883,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cmi.2023.02.016","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T02:16:06Z","timestamp":1677636966000},"page":"714-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of latent tuberculosis infection in incarcerated people: a systematic review"],"prefix":"10.1016","volume":"29","author":[{"given":"Tommaso","family":"Matucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Occhineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostina","family":"Pontarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Puci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Saderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.02.016_bib2","first-page":"348","article-title":"Prevalence of latent Mycobacterium tuberculosis infection in prisoners","volume":"42","author":"Navarro","year":"2016","journal-title":"J\u00a0Bras Pneumol"},{"key":"10.1016\/j.cmi.2023.02.016_bib3","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2468-2667(21)00025-6","article-title":"Incidence and prevalence of tuberculosis in incarcerated populations: a systematic review and meta-analysis","volume":"6","author":"Cords","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.cmi.2023.02.016_bib4","unstructured":"WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/publications\/i\/item\/9789240001503."},{"key":"10.1016\/j.cmi.2023.02.016_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(19)30575-4","article-title":"Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials","volume":"20","author":"Campbell","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib6","article-title":"Tuberculosis and pharmacological interactions: a narrative review","volume":"2","author":"Riccardi","year":"2020","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"10.1016\/j.cmi.2023.02.016_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent tuberculosis infection: recommendations from the national tuberculosis controllers association and CDC","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cmi.2023.02.016_bib9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.02.016_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1871526516666160616111308","article-title":"Adherence to antiretroviral therapy and tuberculosis treatment in a prison of Tehran, Iran","volume":"16","author":"SeyedAlinaghi","year":"2016","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.cmi.2023.02.016_bib11","first-page":"S417","article-title":"Evaluation of an extensive tuberculosis contact investigation in an urban community and jail","volume":"7","author":"Bur","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib12","first-page":"1296","article-title":"Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons","volume":"127","author":"Lobato","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2023.02.016_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0749-3797(02)00583-4","article-title":"Treatment for latent TB in correctional facilities: a challenge for TB elimination","volume":"24","author":"Lobato","year":"2003","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cmi.2023.02.016_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0033-3549(04)50286-8","article-title":"Assessment of tuberculosis screening and management practices of large jail systems","volume":"118","author":"Reichard","year":"2003","journal-title":"Public Health Rep"},{"key":"10.1016\/j.cmi.2023.02.016_bib15","first-page":"1248","article-title":"Contact screening and latent TB infection treatment in Singapore correctional facilities","volume":"9","author":"Chee","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5588\/ijtld.11.0504","article-title":"Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial","volume":"16","author":"Chan","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1078345811435973","article-title":"Isoniazid vs. rifampin for latent tuberculosis infection in jail inmates: toxicity and adherence","volume":"18","author":"White","year":"2012","journal-title":"J\u00a0Correct Health Care"},{"key":"10.1016\/j.cmi.2023.02.016_bib18","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/PHH.0000000000000822","article-title":"High completion rate for 12 weekly doses of isoniazid and rifapentine as treatment for latent Mycobacterium tuberculosis infection in the Federal Bureau of prisons","volume":"25","author":"Schmit","year":"2019","journal-title":"J\u00a0Public Health Manag Pract"},{"key":"10.1016\/j.cmi.2023.02.016_bib19","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1177\/0033354919826557","article-title":"Completion rates, adverse effects, and costs of a 3-month and 9-month treatment regimen for latent tuberculosis infection in California inmates, 2011-2014","volume":"134","author":"Wheeler","year":"2019","journal-title":"Public Health Rep"},{"key":"10.1016\/j.cmi.2023.02.016_bib20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1378\/chest.119.3.833","article-title":"Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates","volume":"119","author":"Bock","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2023.02.016_bib21","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1186\/s12889-021-11271-0","article-title":"Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study","volume":"21","author":"Gatechompol","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cmi.2023.02.016_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203815","article-title":"A\u00a0situational analysis of latent tuberculosis infection among incarcerated population in Japan","volume":"13","author":"Kawatsu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2023.02.016_bib23","article-title":"Can social history variables predict prison inmates' risk for latent tuberculosis infection?","volume":"2012","author":"Weant","year":"2012","journal-title":"Tuberc Res Treat"},{"key":"10.1016\/j.cmi.2023.02.016_bib24","first-page":"3","article-title":"10 a\u00f1osinnovandoeneltratamiento de la infecci\u00f3ntuberculosalatente: comparaci\u00f3n entre pautasest\u00e1ndar y pautascortasentratamientodirectamenteobservado","volume":"13","author":"L\u00f3pez","year":"2011","journal-title":"Rev EspSanidPenit"},{"key":"10.1016\/j.cmi.2023.02.016_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.amepre.2005.06.014","article-title":"Incidence of TB in inmates with latent TB infection: 5-year follow-up","volume":"29","author":"White","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cmi.2023.02.016_bib26","first-page":"306","article-title":"Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin\/pyrazinamide with isoniazid regimens","volume":"8","author":"Lincoln","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib27","series-title":"Guidance on tuberculosis control in vulnerable and hard-to-reach populations","year":"2016"},{"key":"10.1016\/j.cmi.2023.02.016_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102041","article-title":"Missed opportunities in tb clinical practice: how to bend the curve? A medical, social, economic and ethical point of view","volume":"126","author":"Riccardi","year":"2021","journal-title":"Tuberculosis (Edinb)."},{"key":"10.1016\/j.cmi.2023.02.016_bib29","article-title":"Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: an observational and modeling study from Brazil","volume":"16","author":"Mabud","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2023.02.016_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00052-2020","article-title":"Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study","volume":"55","author":"Villa","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.02.016_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/healthcare10020386","article-title":"Not only COVID-19: prevalence and management of latent Mycobacterium tuberculosis infection in three penitentiary facilities in southern Italy","volume":"10","author":"Izzo","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.cmi.2023.02.016_bib32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S1473-3099(21)00052-9","article-title":"Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis","volume":"21","author":"Rustage","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib33","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3201\/eid0811.020306","article-title":"Skin-test screening and tuberculosis transmission among the homeless","volume":"8","author":"Kong","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1525-1446.2006.00605.x","article-title":"A\u00a0targeted testing program for tuberculosis control and prevention among Baltimore city's homeless population","volume":"24","author":"Lashley","year":"2007","journal-title":"Public Health Nurs"},{"key":"10.1016\/j.cmi.2023.02.016_bib35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2458-12-468","article-title":"Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study","volume":"12","author":"Goswami","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cmi.2023.02.016_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218373","article-title":"Using directly observed therapy (DOT) for latent tuberculosis treatment - a hit or a miss? A propensity score analysis of treatment completion among 274 homeless adults in Fulton County, GA","volume":"14","author":"Onwubiko","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2023.02.016_bib37","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.200209-998OC","article-title":"Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis","volume":"167","author":"Stout","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.02.016_bib38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5588\/ijtld.16.0469","article-title":"Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial","volume":"21","author":"Moro","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/cid\/cix505","article-title":"High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine for latent Mycobacterium tuberculosis infection","volume":"65","author":"Sandul","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.016_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3201\/eid1507.080410","article-title":"Latent tuberculosis and active tuberculosis disease rates among the homeless, New York, New York, USA, 1992-2006","volume":"15","author":"McAdam","year":"2009","journal-title":"Emerg Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23000861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23000861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:34:19Z","timestamp":1761118459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1198743X23000861"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.02.016","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of latent tuberculosis infection in incarcerated people: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}